Tetanti AgriBiotech Inc., an agricultural biotechnology company cultivated by Diamond Biofund (TWSE: 6901), signed the first phase of contract with Indonesian Unigreen Technology International Group to start the construction of an organic waste treatment plant, on the ceremony held at Indonesian Trade and Economic Office in Taipei today (28th). The two parties will use the...Read More
No 1 Date of announcement 2023/12/22 Time of announcement 18:55:20 Subject The Company’s Board of Directors resolved to inject capital into the 100% owned subsidiary, Diamond Biofund Ⅱ Inc. Date of events 2023/12/22 To which item it meets paragraph 20 Name and nature of the underlying assets (if preferred shares, the terms...Read More
Published: 2023-12-22 No 1 Date of announcement 2023/12/22 Time of announcement 18:54:18 Subject Announcement for the change of the Company’s Chief Financial Officer and Spokesperson. Date of events 2023/12/22 To which item it meets paragraph 8 Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.) ,financial officer,...Read More
Published: 2023-12-22 No 1 Date of announcement 2023/12/22 Time of announcement 18:54:47 Subject The Company’s Board of Directors resolved to inject capital into the 100% owned subsidiary, Diamond Biofund Ⅰ Inc. Date of events 2023/12/22 To which item it meets paragraph 20 Name and nature of the underlying assets (if preferred shares, the terms...Read More
Published: 2023-12-20 No 1 Date of announcement 2023/12/20 Time of announcement 15:41:53 Subject The Company announces the information about the investor conference of Q4, 2023. Date of events 2023/12/20 To which item it meets paragraph 12 Date of institutional investor conference:2023/12/27 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:online investor conference...Read More
Published: 2023-12-08 No 1 Date of announcement 2023/12/07 Time of announcement 17:21:32 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2023/12/07 To which item it meets paragraph 51 Date of occurrence...Read More
Published: 2023-11-10 Cross-Border Collaboration Facilitates Flagship Biotech Investments Joint News Release Date: November 5th, 2023 Leading Taiwanese and Japanese biotech venture capitals ally. Diamond Biofund from Taiwan and DCI Partners Co., Ltd. (wholly owned by Daiwa Securities Group, referred to as DCI Partners) from Japan jointly announced that the two parties have established a cross-border...Read More
Published: 2023-11-09 No 1 Date of announcement 2023/11/08 Time of announcement 19:34:43 Subject The Company’s 2023Q3 financial statements have been approved by the Board of Directors Date of events 2023/11/08 To which item it meets paragraph 31 Date of submission to the board of directors or approval by the board of directors:2023/11/08 Date of...Read More
Published: 2023-11-09 Diamond Biofund invests in full speed after its listing in Taiwian Stock Exchange. Following investing in Syncell, Diamond Biofund has announced on Nov. 8th, 2023 a significant addition of US$6.35 million investment in StemCyte to support its novel cell therapy entering into the global market and its successful capital raise of over US$25...Read More
Published: 2023-11-08 No 1 Date of announcement 2023/11/07 Time of announcement 17:29:25 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2023/11/07 To which item it meets paragraph 51 Date of occurrence...Read More
